Serum Markers in Preeclamptic Women

This study has been completed.

Sponsor:

Information provided by:

Oslo University Hospital

ClinicalTrials.gov Identifier:

NCT01361737

First received: May 25, 2011

Last updated: July 3, 2011

Last verified: May 2011

History of Changes

Purpose

Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?

Condition
Preeclampsia


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Retrospective

Resource links provided by NLM:

Genetics Home Reference related topics: preeclampsia

U.S. FDA Resources

Further study details as provided by Oslo University Hospital:


Study Start Date:	January 1999
Study Completion Date:	May 2004
Primary Completion Date:	January 1999 (Final data collection date for primary outcome measure)

Groups/Cohorts
preeclampsia Control group: 86 healthy women not developing preeclampsia (PE) Case group: 43 women developing PE

Eligibility


Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

Norwegian pregnant women

Criteria

Inclusion Criteria:

previous healthy

Exclusion Criteria:

Previous inflammatory diseases

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01361737

Locations


Norway
Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0027

Sponsors and Collaborators

Oslo University Hospital

More Information

No publications provided


Responsible Party:	Oslo University Hospital, Rikshospitalet, OsloUH
ClinicalTrials.gov Identifier:	NCT01361737 History of Changes
Other Study ID Numbers:	NOSERPE11
Study First Received:	May 25, 2011
Last Updated:	July 3, 2011
Health Authority:	Norway: University of Oslo

Keywords provided by Oslo University Hospital:


Preeclampsia serological bio-bank adiponectin suPAR

ClinicalTrials.gov processed this record on March 01, 2015

To Top